The Dow Chemical Company
Dowpharma, a business unit within Dow, serves the pharmaceutical and biopharmaceutical industries with innovative technology, products, and services for clients in drug discovery, development, manufacturing, and delivery. Dowpharma combines the resources and capabilities of several offerings to create a single, market-focused organization with broad service and support capabilities for large and emerging pharmaceutical companies.
Dowpharma services include process development, route selection, methods development, custom solubilization, including BioAqueous solubilization services; chiral capabilities, and associated analytical services; biotargeted radiopharmaceuticals development through ChelaMed radiopharmaceutical services as well as manufacturing and scale-up from feasibility, through clinical trials, to commercial manufacturing. Dowpharma currently manufactures small molecule Active Pharmaceutical Ingredients (APIs) and intermediates, nucleic acid medicines, cGMP polymers, peptides and therapeutic proteins from microbial fermentation, including Pfēnex Expression Technology, a Pseudomonas-based system, and plant-based systems.
Dowpharma draws upon over 30 years of excellent cGMP regulatory compliance in the organic synthesis of APIs and pharmaceutical intermediates with the ability to provide client support in filing and validation strategies. Dowpharma operates research, process development, and manufacturing facilities in North America and Europe.
Last Updated: 07-12-05